board WHOcte. Soft tissue and bone tumours. 5th ed ed. World Health Organization classification of tumours. World Health Organization International Agency for Research on Cancer; 2020.

Ladanyi M, Lui MY, Antonescu CR, Krause-Boehm A, Meindl A, Argani P, et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene. 2001;20(1):48–57. https://doi.org/10.1038/sj.onc.1204074.

Article  CAS  PubMed  Google Scholar 

S Joyama, T Ueda, K Shimizu, I Kudawara, M Mano, H Funai et al. 1999 Chromosome rearrangement at 17q25 and xp11.2 in alveolar soft-part sarcoma: A case report and review of the literature. Cancer 86(7) 1246–1250.

Fujiwara T, Kunisada T, Nakata E, Nishida K, Yanai H, Nakamura T, et al. Advances in treatment of alveolar soft part sarcoma: an updated review. Jpn J Clin Oncol. 2023;53(11):1009–18. https://doi.org/10.1093/jjco/hyad102.

Article  PubMed  PubMed Central  Google Scholar 

Li W, Zhang S, Fan W, Li D, Tian H, Che D, et al. Sonographic imaging features of alveolar soft part sarcoma: Case series and literature review. Medicine. 2022;101(46): e31905. https://doi.org/10.1097/md.0000000000031905.

Article  PubMed  PubMed Central  Google Scholar 

Hashimoto H. Incidence of soft tissue sarcomas in adults. Curr Top Pathol. 1995;89:1–16. https://doi.org/10.1007/978-3-642-77289-4_1.

Article  CAS  PubMed  Google Scholar 

Wang H, Jacobson A, Harmon DC, Choy E, Hornicek FJ, Raskin KA, et al. Prognostic factors in alveolar soft part sarcoma: A SEER analysis. J Surg Oncol. 2016;113(5):581–6. https://doi.org/10.1002/jso.24183.

Article  PubMed  Google Scholar 

PH Lieberman, MF Brennan, M Kimmel, RA Erlandson, P Garin-Chesa, BY Flehinger. 1989 Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer 63(1) 1–13. doi:https://doi.org/10.1002/1097-0142(19890101)63:1<1::aid-cncr2820630102>3.0.co;2-e.

de Barros GF, Hakim JR, Passos JP, Perron M, Odashiro AN. Orbital alveolar soft part sarcoma: case report and literature review. Can J Ophthalmol. 2019;54(6):e292–4. https://doi.org/10.1016/j.jcjo.2019.02.005.

Article  PubMed  Google Scholar 

Eley KA, Afzal T, Shah KA, Watt-Smith SR. Alveolar soft-part sarcoma of the tongue: report of a case and review of the literature. Int J Oral Maxillofac Surg. 2010;39(8):824–6. https://doi.org/10.1016/j.ijom.2010.02.020.

Article  CAS  PubMed  Google Scholar 

Portera CA Jr, Ho V, Patel SR, Hunt KK, Feig BW, Respondek PM, et al. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer. 2001;91(3):585–91. https://doi.org/10.1002/1097-0142(20010201)91:3%3c585::aid-cncr1038%3e3.0.co;2-0.

Article  PubMed  Google Scholar 

Kayton ML, Meyers P, Wexler LH, Gerald WL, LaQuaglia MP. Clinical presentation, treatment, and outcome of alveolar soft part sarcoma in children, adolescents, and young adults. J Pediatr Surg. 2006;41(1):187–93. https://doi.org/10.1016/j.jpedsurg.2005.10.023.

Article  PubMed  Google Scholar 

Fujiwara T, Nakata E, Kunisada T, Ozaki T, Kawai A. Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study. BMC Cancer. 2022;22(1):891. https://doi.org/10.1186/s12885-022-09968-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lazar AJ, Das P, Tuvin D, Korchin B, Zhu Q, Jin Z, et al. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma. Clin Cancer Res. 2007;13(24):7314–21. https://doi.org/10.1158/1078-0432.Ccr-07-0174.

Article  CAS  PubMed  Google Scholar 

Penel N, Coindre JM, Giraud A, Terrier P, Ranchere-Vince D, Collin F, et al. Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers. Cancer. 2018;124(6):1179–87. https://doi.org/10.1002/cncr.31176.

Article  PubMed  Google Scholar 

Soheilifar MH, Taheri RA, Zolfaghari Emameh R, Moshtaghian A, Kooshki H, Motie MR. Molecular landscape in alveolar soft part sarcoma: implications for molecular targeted therapy. Biomed Pharmacother. 2018;103:889–96. https://doi.org/10.1016/j.biopha.2018.04.117.

Article  CAS  PubMed  Google Scholar 

Kim M, Kim TM, Keam B, Kim YJ, Paeng JC, Moon KC, et al. A phase II trial of pazopanib in patients with metastatic alveolar soft part sarcoma. Oncologist. 2019;24(1):20-e9. https://doi.org/10.1634/theoncologist.2018-0464.

Article  CAS  PubMed  Google Scholar 

Judson I, Morden JP, Kilburn L, Leahy M, Benson C, Bhadri V, et al. Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial. Lancet Oncol. 2019;20(7):1023–34. https://doi.org/10.1016/s1470-2045(19)30215-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schöffski P, Wozniak A, Kasper B, Aamdal S, Leahy MG, Rutkowski P, et al. Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 “CREATE.” Ann Oncol. 2018;29(3):758–6578. https://doi.org/10.1093/annonc/mdx774.

Article  PubMed  Google Scholar 

Jagodzińska-Mucha P, Świtaj T, Kozak K, Koseła-Paterczyk H, Klimczak A, Ługowska I, et al. Long-term results of therapy with sunitinib in metastatic alveolar soft part sarcoma. Tumori. 2017;103(3):231–5. https://doi.org/10.5301/tj.5000617.

Article  CAS  PubMed  Google Scholar 

Kondo T. Current status and future outlook for patient-derived cancer models from a rare cancer research perspective. Cancer Sci. 2021;112(3):953–61. https://doi.org/10.1111/cas.14669.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ono T, Noguchi R, Yoshimatsu Y, Sin Y, Tsuchiya R, Akiyama T, et al. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone. Hum Cell. 2023;36(5):1804–12. https://doi.org/10.1007/s13577-023-00928-0.

Article  CAS  PubMed  Google Scholar 

Billiau A, Edy VG, Heremans H, Van Damme J, Desmyter J, Georgiades JA, et al. Human interferon: mass production in a newly established cell line, MG-63. Antimicrob Agents Chemother. 1977;12(1):11–5. https://doi.org/10.1128/aac.12.1.11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dickson BC, Chung CT, Hurlbut DJ, Marrano P, Shago M, Sung YS, et al. Genetic diversity in alveolar soft part sarcoma: A subset contain variant fusion genes, highlighting broader molecular kinship with other MiT family tumors. Genes Chromosomes Cancer. 2020;59(1):23–9. https://doi.org/10.1002/gcc.22803.

Article  CAS  PubMed  Google Scholar 

Langhans SA. Three-dimensional in vitro cell culture models in drug discovery and drug repositioning. Front Pharmacol. 2018;9:6. https://doi.org/10.3389/fphar.2018.00006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jensen C, Teng Y. Is it time to start transitioning from 2D to 3D cell culture? Front Mol Biosci. 2020;7:33. https://doi.org/10.3389/fmolb.2020.00033.

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Sullivan Coyne G, Naqash AR, Sankaran H, Chen AP. Advances in the management of alveolar soft part sarcoma. Curr Probl Cancer. 2021;45(4): 100775. https://doi.org/10.1016/j.currproblcancer.2021.100775.

Article  PubMed  Google Scholar 

Paoluzzi L, Maki RG. Diagnosis, prognosis, and treatment of alveolar soft-part sarcoma: a review. JAMA Oncol. 2019;5(2):254–60. https://doi.org/10.1001/jamaoncol.2018.4490.

Article  PubMed  Google Scholar 

Schuetze SM, Bolejack V, Choy E, Ganjoo KN, Staddon AP, Chow WA, et al. Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor. Cancer. 2017;123(1):90–7. https://doi.org/10.1002/cncr.30379.

Article  CAS  PubMed  Google Scholar 

Wadman M. FDA no longer has to require animal testing for new drugs. Science. 2023;379(6628):127–8. https://doi.org/10.1126/science.adg6276.

Article  ADS  CAS  PubMed  Google Scholar 

Nuwer R. US agency seeks to phase out animal testing. Nature. 2022. https://doi.org/10.1038/d41586-022-03569-9.

Article  PubMed  Google Scholar 

Cauli E, Polidoro MA, Marzorati S, Bernardi C, Rasponi M, Lleo A. Cancer-on-chip: a 3D model for the study of the tumor microenvironment. J Biol Eng. 2023;17(1):53. https://doi.org/10.1186/s13036-023-00372-6.

Article  PubMed  PubMed Central  Google Scholar